Journal of Cancer Research and Clinical Oncology

Article	Citations
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning	91
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma	90
Estimating the global burden of Epstein–Barr virus-related cancers	84
Role of lung and gut microbiota on lung cancer pathogenesis	77
Artificial intelligence in gastric cancer: a systematic review	68
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review	64
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients	56
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study	55
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy	53
Cannabinoids in the landscape of cancer	52
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters	50
Gut microbiota-derived metabolites in CRC progression and causation	45
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression	43
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer	41
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes	38
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells	37
Cancer patients’ perspective on shared decision-making and decision aids in oncology	36
Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art	35
Oncology services in corona times: a flash interview among German cancer patients and their physicians	35
3D tumor angiogenesis models: recent advances and challenges	32
Targeting tumor vascularization: promising strategies for vascular normalization	31
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials	31
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma	31
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression	30
Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma	30

CD36: an emerging therapeutic target for cancer and its molecular mechanisms	30
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments	30
Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies	29
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	29
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT	29
Implications of flavonoids as potential modulators of cancer neovascularity	29
Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature	29
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA	29
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observati	28
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma	28
Predictive biomarkers in gastric cancer	27
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas	27
The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis	27
Melatonin: an endogenous miraculous indolamine, fights against cancer progression	27
The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation	26
Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies	26
Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma	26
Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis	26
Inflammatory markers in autoimmunity induced by checkpoint inhibitors	25
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review	25
Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential	25
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing	25
MAPK signaling pathway-targeted marine compounds in cancer therapy	25
Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome	24
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma	24
Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen	24
The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma	24
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes	23
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer	23
Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively	23
Current trends of targeted therapy for oral squamous cell carcinoma	23
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data	23
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy	23
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	23
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board	22
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning	22
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort	22
High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)	22
Human TERT promoter mutations as a prognostic biomarker in glioma	22
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis	21
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer	21
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis	21
Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation	21
Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning	21
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy	21
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective	21
Active HPV infection and its influence on survival in head and neck squamous-cell cancer	21
PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions	20
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases	20
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer	20

Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective singl	20
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma	20
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics	20
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	20
Large language models for oncological applications	20
Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach	20
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California	20
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer	19
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China	19
Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors	19
Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis	19
Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects	19
Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI	19
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy	18
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres	18
Radiotherapy resistance: identifying universal biomarkers for various human cancers	18
Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer	18
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach	18
Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study	18
Multiple functions of p21 in cancer radiotherapy	18
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin	18
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer	18
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death	18
Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer	17
Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis	17
TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction	17
Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review	17
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases	17
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways	17
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma	17
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy	17
First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation	17
Risk of lung cancer and renin–angiotensin blockade: a concise review	17
Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis	17
Tumor patients’ fears and worries and perceived changes of specific attitudes, perceptions and behaviors due to the COVID-19 pandemic are still relevant	17
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma	16
Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries	16
Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany	16
SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis	16
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020	16
Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements	16
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey	16
Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma	16
Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation and attitudes	16
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results	16
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis	15
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1	15
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment	15
Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review	15
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China	15
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis	15
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling	15
Molecular targeted treatment and drug delivery system for gastric cancer	15
Diagnostic approach in hepatic lymphoma: radiological imaging findings and literature review	15
Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer	15
Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers	15
Harvest of at least 18 lymph nodes is associated with improved survival in patients with pN0 colon cancer: a retrospective cohort study	15
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network	15
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients	15
Cancer risks in patients with vitiligo: a Mendelian randomization study	15
Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare	15
Expression of H3K4me3 and H3K9ac in breast cancer	15
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study	14
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells	14
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers	14
Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma	14
Immunological combination treatment holds the key to improving survival in pancreatic cancer	14
Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer	14
The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review	14
Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis	14
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity	14
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)	14
Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer	14
An overview and a roadmap for artificial intelligence in hematology and oncology	14
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer	14
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma	14
Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection	14
Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection	13
Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer	13
Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment	13

Genomic landscape of colorectal carcinogenesis	13
Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases	13
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C	13
IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer	13
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance	13
Triple negative breast cancer: approved treatment options and their mechanisms of action	13
Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral res	13
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer	13
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases	13
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres	13
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized	13
Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas	13
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia	13
Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes	13
Ten–eleven translocase: key regulator of the methylation landscape in cancer	13
SWI/SNF chromatin remodeling complex alterations in meningioma	13
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial	13
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases	12
Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC	12
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers	12
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease	12
G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival	12
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study	12
Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1	12
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis	12
Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification	12
EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis	12
A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis	12
UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines	12
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity	12
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping	12
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma	12
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study	12
Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma	12
Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion	12
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small	12
Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis	12
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma	12
Aurora B kinase: a potential drug target for cancer therapy	12
Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients	12
Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo	12
Association between various thyroid gland diseases, TSH values and thyroid cancer: a case–control study	12
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT	12
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing	12
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications	12
Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms	11
Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma	11
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard tre	11
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma	11
BDNF and its signaling in cancer	11
Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules	11
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome	11
Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy	11
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers	11
Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents	11
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling	11
Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1	11
Gamma-delta T cells stimulate IL-6 production by pancreatic stellate cells in pancreatic ductal adenocarcinoma	11
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer	11
Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1	11
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study	11
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities	11
High MICB expression as a biomarker for good prognosis of colorectal cancer	11
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care	11
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis	11
Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing	11
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression	11
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients	11
Water therapies (hydrotherapy, balneotherapy or aqua therapy) for patients with cancer: a systematic review	11
Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells	11
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group	10
Expression of estrogen-related receptors in ovarian cancer and impact on survival	10
Experimental and clinical studies on radiation and curcumin in human glioma	10
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials	10
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer	10
Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP	10
Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database	10
Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review	10
Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost	10
Activation-induced cytidine deaminase: in sickness and in health	10
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time	10
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience	10
Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma	10
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases	10
Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series	10
Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis	10
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)	10
Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis	10
Cancer-associated inflammation: pathophysiology and clinical significance	10
Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma	10
Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy	10
Applications of artificial intelligence multiomics in precision oncology	10
Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors	10
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation	10
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer	10